Post-Measles Infection Considerations

Critical Timeline: Encephalitis Risk Window

Encephalitis onset follows a non-random distribution with peak occurrence approximately 10 days after initial infection, consistent with the timing observed in both wild measles virus infection and vaccine-associated cases 1
Encephalitis develops in approximately 1 per 1,000 persons infected with wild measles virus, making it a rare but serious complication with potential for permanent CNS impairment 1

Seizures (noting that simple febrile seizures during the acute phase are different from encephalitic seizures) 1
Focal neurological deficits or progressive neurological deterioration 2

Ensure vitamin A supplementation protocol has been properly administered, as this is the only evidence-based intervention to reduce measles mortality: Standard dosing: 200,000 IU orally for patients ≥12 months; 100,000 IU for children <12 months 3
A second dose should have been given on day 2 for complicated measles (pneumonia, otitis media, croup, diarrhea with dehydration, or neurological problems) 3
If eye symptoms of vitamin A deficiency are present (xerosis, Bitot's spots, keratomalacia, corneal ulceration), a third dose of 200,000 IU should be administered 1-4 weeks after initial doses 3

Evaluate nutritional status and enroll in feeding programs if indicated, as malnutrition significantly increases complication rates and hospital stay duration 3

Patients remain contagious from 4 days before through 4 days after rash onset, meaning by day 10 post-infection (assuming rash appeared around day 3-4 of illness), most patients are no longer infectious 3
However, immunocompromised patients may shed virus for prolonged periods and require extended isolation precautions 3

Medical personnel should be removed from patient contact for 5-21 days after exposure if they lack immunity 4
All healthcare workers entering rooms of suspected or confirmed measles cases must wear N95 respirators regardless of presumptive immunity status 3, 5

May require extended monitoring and should have received immune globulin (0.5 mL/kg, maximum 15 mL) if exposed 3

Should have received immune globulin (0.25 mL/kg, maximum 15 mL) within 6 days of exposure 3

Occurs in approximately 4-11 per 100,000 measles-infected individuals 2
Risk is highest in children infected before age 2 years 2
Early symptoms include behavioral changes followed by myoclonic jerks and progressive neurological deterioration 2

Ensure all susceptible contacts received MMR vaccine within 72 hours of exposure or immune globulin within 6 days 4, 6
Contacts who received immune globulin should receive measles vaccine 3 months later 4

Do not assume the patient is "out of the woods" at 10 days—encephalitis characteristically presents around this time 1
Do not forget vitamin A supplementation, which is often overlooked but critical for reducing mortality 3
Do not use aspirin for fever control in children and adolescents due to Reye syndrome risk 1
Do not rely solely on clinical improvement—maintain vigilance for secondary bacterial infections that may require antibiotic therapy 3